These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17575138

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
    Leveque J, Foucher F, Havouis R, Desury D, Grall JY, Moulinoux JP.
    Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
    [Abstract] [Full Text] [Related]

  • 6. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
    Belosay A, Brodie AM, Njar VC.
    Cancer Res; 2006 Dec 01; 66(23):11485-93. PubMed ID: 17145897
    [Abstract] [Full Text] [Related]

  • 7. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.
    Vendrell JA, Bieche I, Desmetz C, Badia E, Tozlu S, Nguyen C, Nicolas JC, Lidereau R, Cohen PA.
    Endocr Relat Cancer; 2005 Mar 01; 12(1):75-92. PubMed ID: 15788640
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens.
    Sabnis G, Goloubeva O, Jelovac D, Schayowitz A, Brodie A.
    Clin Cancer Res; 2007 May 01; 13(9):2751-7. PubMed ID: 17473209
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Nutr Cancer; 2007 May 01; 58(2):162-70. PubMed ID: 17640162
    [Abstract] [Full Text] [Related]

  • 17. STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.
    Newman SP, Foster PA, Stengel C, Day JM, Ho YT, Judde JG, Lassalle M, Prevost G, Leese MP, Potter BV, Reed MJ, Purohit A.
    Clin Cancer Res; 2008 Jan 15; 14(2):597-606. PubMed ID: 18223236
    [Abstract] [Full Text] [Related]

  • 18. Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.
    Christov K, Grubbs CJ, Shilkaitis A, Juliana MM, Lubet RA.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5488-96. PubMed ID: 17875779
    [Abstract] [Full Text] [Related]

  • 19. Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions.
    Pontiggia O, Rodriguez V, Fabris V, Raffo D, Bumaschny V, Fiszman G, de Kier Joffé EB, Simian M.
    Breast Cancer Res Treat; 2009 Jul 15; 116(2):247-55. PubMed ID: 18622696
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.